CLINICAL TRIALS NETWORK OF TENNESSEE (EIN 823632649) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2017

Legal Domicile

Principal Officer

DR SAMUEL DAGOGO-JACK

Phone

9018661428

Tax Period

2023-07-01 to 2024-06-30

CLINICAL TRIALS NETWORK OF TENNESSEE, founded in 2017, is a community nonprofit that reported $2.9M in total revenue in fiscal year 2023. Revenue grew 16% year-over-year, indicating healthy expansion.

Mission

CTN2'S MISSION IS TO ADVANCE RESEARCH FOR THE UNIVERSITY OF TENNESSEE BY AGGREGATING AND SUPPORTING RESEARCH CONDUCTED BY UT FACULTY INVESTIGATORS ACROSS THE STATE OF TENNESSEE. AS A SITE MANAGEMENT ORGANIZATION, CTN2 PROVIDES CLINICAL TRIAL RELATED SERVICES TO SPONSORS IN SEARCH OF ACCESS TO MULTIPLE SITES, AND CLINICAL TRIAL RELATED SERVICES TO SITES WITHIN THE CTN2 NETWORK SUCH AS ENTERPRISE DATA WAREHOUSING, CLINICAL TRIAL BUDGETING AND CONTRACTING, INSTITUTIONAL REVIEW BOARD FACILITATION, SITE MANAGEMENT, SITE QUALITY ASSURANCE, AND SPONSOR RELATIONSHIP MANAGEMENT.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $356,658

Program Service Revenue $2,523,601

Investment Income $0

Other Revenue $0

TOTAL REVENUE $2,880,259

Expense Breakdown

Grants Paid $0

Salaries & Benefits $387,421

Fundraising Expenses $0

Program Expenses $3,022,457

Other Expenses $2,686,536

TOTAL EXPENSES $3,073,957

Year-over-Year Comparison

	2023	2022	Change
Revenue	$2,880,259	$2,488,939	+0.2%
Expenses	$3,073,957	$2,598,412	+0.2%
Net Income	$-193,698	$-109,473	+0.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$121,794

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
SANDRA DODD	SITE LIAISON	40.00	Highest	$125,308	$19,684	$144,992
PHIL CESTARO	EXECUTIVE DI	40.00	Officer	$121,794	$0	$121,794
DR JAMES BEATY	BOARD MEMBER	1.00	Director	$0	$0	$0
DR PETER BUCKLEY	BOARD MEMBER	1.00	Director	$0	$0	$0
WESLEY BYERLY	BOARD MEMBER	1.00	Director	$0	$0	$0
DR BRAD CANADA	BOARD MEMBER	1.00	Director	$0	$0	$0
DR MARTIN CROCE	BOARD MEMBER	1.00	Director	$0	$0	$0
BRIAN EVANS	BOARD MEMBER	1.00	Director	$0	$0	$0
DR MAHALAXMI KRISHNAMURTHY	BOARD MEMBER	1.00	Director	$0	$0	$0
KIM MASON	BOARD MEMBER	1.00	Director	$0	$0	$0
DR FRANK MCGREW	BOARD MEMBER	1.00	Director	$0	$0	$0
JONATHAN MOORMAN	BOARD MEMBER	1.00	Director	$0	$0	$0
DR GIUSEPPE PIZZORNO	BOARD MEMBER	1.00	Director	$0	$0	$0
DR TODD PONZIO	BOARD MEMBER	1.00	Director	$0	$0	$0
ERIC SCHNAPP	BOARD MEMBER	1.00	Director	$0	$0	$0
DR ANIL SHANKER	BOARD MEMBER	1.00	Director	$0	$0	$0
DR GEOFFREY SMALLWOOD	BOARD MEMBER	1.00	Director	$0	$0	$0
DR SUE THEUS	BOARD MEMBER	1.00	Director	$0	$0	$0
CLARENCE WATRIDGE	BOARD MEMBER	1.00	Director	$0	$0	$0
DR SAMUEL DAGOGO-JACK	PRESIDENT	40.00	Officer	$0	$0	$0
WILIAM MASON	GENERAL COUN	1.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$2,880,259	$3,073,957	No data	$-193,698
2023	$2,488,939	$2,598,412	$448,219	$-109,473
2022	$2,639,263	$2,586,759	$721,235	$52,504
2021	$1,387,113	$1,559,798	$511,866	$-172,685
2020	$1,179,617	$1,113,316	$543,690	$66,301
2019	$1,010,615	$773,591	$404,142	$237,024

CLINICAL TRIALS NETWORK OF TENNESSEE